Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity

ClinicalTrials.gov ID: NCT00339014

Public ClinicalTrials.gov record NCT00339014. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Dose Parallel, Randomized, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Multiple Regimens of the Combination of Zonisamide CR Plus Bupropion SR in the Treatment of Subjects With Uncomplicated Obesity

Study identification

NCT ID
NCT00339014
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Orexigen Therapeutics, Inc
Industry
Enrollment
611 participants

Conditions and interventions

Conditions

Interventions

  • Zonisamide CR and Bupropion SR Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2006
Primary completion
Jul 31, 2007
Completion
Jul 31, 2007
Last update posted
Apr 21, 2008

2006 – 2007

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
14
Facility City State ZIP Site status
SelfCenter, PC Fairhope Alabama 36532
UCLA Center for Human Nutrition Los Angeles California 90095
Scripps Clinic Del Mar San Diego California 92130
Center for Human Nutrition University of Colorado Health Sciences Center Denver Colorado 80220
George Washington University Weight Management Program Washington D.C. District of Columbia 20037
CSRA Partners in Health, Inc Augusta Georgia 30909
Springfield Diabetes and Endocrine Center Springfield Illinois 62704
Pennington Biomedical Research Center Baton Rouge Louisiana 70808
Nutrition and Weight Mangement Center Boston Medical Center Boston Massachusetts 02118
Center for Nutrition and Metabolic Diseases Reno Nevada 89557
Comprehensive Weight Control Program New York New York 10021
Center for Nutrition and Preventive Medicine Charlotte North Carolina 28211
MUSC Weight Mnagement Center Charleston South Carolina 29425
The Cooper Institute Dallas Texas 75230
Baylor Endocrine Center Dallas Texas 75246

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00339014, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2008 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00339014 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →